{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:23Z","timestamp":1791994583721,"version":"4.4.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","award":["RS-2022-00165917"],"award-info":[{"award-number":["RS-2022-00165917"]}],"id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune bullous diseases (AIBDs) are a group of life-threatening blistering diseases caused by autoantibodies that target proteins in the skin and mucosa. Autoantibodies are the most important mediator in the pathogenesis of AIBDs, and various immune mechanisms contribute to the production of these pathogenic autoantibodies. Recently, significant progress has been made in understanding how CD4<jats:sup>+<\/jats:sup> T cells drive autoantibody production in these diseases. Here, we review the critical role of CD4<jats:sup>+<\/jats:sup> T cells in the production of pathogenic autoantibodies for the initiation and perpetuation of humoral response in AIBDs. To gain an in-depth understanding of CD4<jats:sup>+<\/jats:sup> T-cell pathogenicity, antigen specificity, and mechanisms of immune tolerance, this review covers comprehensive mouse and human studies of pemphigus and bullous pemphigoid. Further exploration of pathogenic CD4<jats:sup>+<\/jats:sup> T cells will potentially provide immune targets for improved treatment of AIBDs.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1161927","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:39:12Z","timestamp":1681709952000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Understanding CD4+ T cells in autoimmune bullous diseases"],"prefix":"10.3389","volume":"14","author":[{"given":"A Yeong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1172\/JCI117349","article-title":"Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus","volume":"94","author":"Amagai","year":"1994","journal-title":"J Clin Invest"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90360-b","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01259","article-title":"Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa","volume":"10","author":"Kim","year":"2019","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000332848","article-title":"Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients","volume":"223","author":"Kim","year":"2011","journal-title":"Dermatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16752","article-title":"Updated S2k guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European academy of dermatology and venereology (Eadv)","volume":"34","author":"Joly","year":"2020","journal-title":"J Eur Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10411.x","article-title":"Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients","volume":"165","author":"Kim","year":"2011","journal-title":"Br J Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2116","article-title":"Efficacy of rituximab for pemphigus: a systematic review and meta-analysis of different regimens","volume":"95","author":"Wang","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932909","article-title":"Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients","volume":"13","author":"Song","year":"2022","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00226","article-title":"The genetics of pemphigus vulgaris","volume":"5","author":"Vodo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363939","article-title":"Dissecting the associations of endemic pemphigus foliaceus (Fogo selvagem) with hla-Drb1 alleles and genotypes","volume":"4","author":"Pavoni","year":"2003","journal-title":"Genes Immun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the Drb1*03 allele","volume":"20","author":"Martel","year":"2003","journal-title":"J Autoimmun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11040.x","article-title":"Association between hla-Drb1 polymorphisms and pemphigus vulgaris: a meta-analysis","volume":"167","author":"Yan","year":"2012","journal-title":"Br J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.25.11935","article-title":"Structural basis for major histocompatibility complex (Mhc)-linked susceptibility to autoimmunity: charged residues of a single mhc binding pocket confer selective presentation of self-peptides in pemphigus vulgaris","volume":"92","author":"Wucherpfennig","year":"1995","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1172\/JCI119130","article-title":"Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris","volume":"99","author":"Lin","year":"1997","journal-title":"J Clin Invest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.1.635","article-title":"Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (Pv) and healthy carriers of pv-associated hla class ii alleles","volume":"170","author":"Veldman","year":"2003","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401081","article-title":"Pathogenic igg antibodies against desmoglein 3 in pemphigus vulgaris are regulated by hla-Drb1*04:02-Restricted T cells","volume":"193","author":"Eming","year":"2014","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.celrep.2019.06.066","article-title":"Single-cell analysis suggests that ongoing affinity maturation drives the emergence of pemphigus vulgaris autoimmune disease","volume":"28","author":"Cho","year":"2019","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8748","article-title":"Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus","volume":"105","author":"Amagai","year":"2000","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.03.036","article-title":"Targeting inducible costimulator expressed on Cxcr5(+)Pd-1(+) T-h cells suppresses the progression of pemphigus vulgaris","volume":"146","author":"Kim","year":"2020","journal-title":"J Allergy Clin Immun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature12058","article-title":"Follicular T-helper cell recruitment governed by bystander b cells and icos-driven motility","volume":"496","author":"Xu","year":"2013","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141432","article-title":"Icos maintains the T follicular helper cell phenotype by down-regulating kruppel-like factor 2","volume":"212","author":"Weber","year":"2015","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57379","article-title":"Desmoglein 3-specific Cd4+ T cells induce pemphigus vulgaris and interface dermatitis in mice","volume":"121","author":"Takahashi","year":"2011","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00019","article-title":"Post-aire maturation of thymic medullary epithelial cells involves selective expression of keratinocyte-specific autoantigens","volume":"3","author":"Wang","year":"2012","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.330","article-title":"Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance","volume":"131","author":"Wada","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxr020","article-title":"Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris","volume":"23","author":"Yokoyama","year":"2011","journal-title":"Int Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2026763118","article-title":"Peripheral tolerance by treg Via constraining Ox40 signal in autoreactive T cells against desmoglein 3, a target antigen in pemphigus","volume":"118","author":"Iriki","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0923-1811(00)00158-4","article-title":"Predominant Igg4 subclass in autoantibodies of pemphigus vulgaris and foliaceus","volume":"26","author":"Futei","year":"2001","journal-title":"J Dermatol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00086.x","article-title":"Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals","volume":"110","author":"Hertl","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.11.008","article-title":"Immunophenotyping in pemphigus reveals a T(H)17\/T(Fh)17 cell-dominated immune response promoting desmoglein 1\/3-specific autoantibody production","volume":"147","author":"Holstein","year":"2021","journal-title":"J Allergy Clin Immun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1684\/ejd.2013.2177","article-title":"The imbalance of Th17 and regulatory T cells in pemphigus patients","volume":"23","author":"Xu","year":"2013","journal-title":"Eur J Dermatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.10.6468","article-title":"Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris","volume":"172","author":"Veldman","year":"2004","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.032","article-title":"Pivotal role of lesional and perilesional T\/B lymphocytes in pemphigus pathogenesis","volume":"137","author":"Yuan","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jid.2019.07.717","article-title":"Autoreactive b cell differentiation in diffuse ectopic lymphoid-like structures of inflamed pemphigus lesions","volume":"140","author":"Zhou","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700016","article-title":"Tolerance induction by the blockade of Cd40\/Cd154 interaction in pemphigus vulgaris mouse model","volume":"126","author":"Aoki-Ota","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.901239","article-title":"Immunotherapy for pemphigus: present and future","volume":"9","author":"Yuan","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114812","article-title":"Isolation of a human epidermal cdna corresponding to the 180-kd autoantigen recognized by bullous pemphigoid and herpes gestationis sera. immunolocalization of this protein to the hemidesmosome","volume":"86","author":"Diaz","year":"1990","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116368","article-title":"Human autoantibodies against the 230-kd bullous pemphigoid antigen (Bpag1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kd bullous pemphigoid antigen (Bpag2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin","volume":"91","author":"Ishiko","year":"1993","journal-title":"J Clin Invest"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.5598","article-title":"Mixed individual-aggregate data on all-cause mortality in bullous pemphigoid: a meta-analysis","volume":"157","author":"Tedbirt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.094","article-title":"Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: a united states population-level analysis","volume":"86","author":"Wongvibulsin","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.2158","article-title":"Evaluation of risk of bullous pemphigoid with initiation of dipeptidyl peptidase-4 inhibitor vs second-generation sulfonylurea","volume":"156","author":"Lee","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15649","article-title":"An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone","volume":"177","author":"Sticherling","year":"2017","journal-title":"Br J Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)30560-3","article-title":"Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial","volume":"389","author":"Williams","year":"2017","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdermsci.2016.11.003","article-title":"A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid","volume":"85","author":"Amagai","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19890","article-title":"Mortality and clinical response of patients with bullous pemphigoid treated with rituximab","volume":"185","author":"Yoo","year":"2021","journal-title":"Br J Dermatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European academy of dermatology and venereology (Eadv)","volume":"36","author":"Borradori","year":"2022","journal-title":"J Eur Acad Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jdermsci.2020.05.010","article-title":"Genetic predisposition to bullous pemphigoid","volume":"100","author":"Zhang","year":"2020","journal-title":"J Dermatol Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903101","article-title":"A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen","volume":"184","author":"Ujiie","year":"2010","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01410","article-title":"Immune reaction to type xvii collagen induces intramolecular and intermolecular epitope spreading in experimental bullous pemphigoid models","volume":"10","author":"Ujiie","year":"2019","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2011.10.002","article-title":"Noncollagenous 16a domain of type xvii collagen-reactive Cd4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model","volume":"142","author":"Ujiie","year":"2012","journal-title":"Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-1811(02)00109-3","article-title":"Bp180 Elisa using bacterial recombinant Nc16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068145","article-title":"Follicular helper T cells (Tfh) and il-21 involvement in the pathogenesis of bullous pemphigoid","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700958","article-title":"A pathogenic role for ige in autoimmunity: bullous pemphigoid ige reproduces the early phase of lesion development in human skin grafted to Nu\/Nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of ige autoantibodies against Bp180 with bullous pemphigoid disease activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"Budinger","year":"1998","journal-title":"J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00153.x","article-title":"Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain","volume":"115","author":"Lin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.03.1515","article-title":"Identification of immunodominant Th2-cell epitopes in Chinese patients with bullous pemphigoid","volume":"138","author":"Zhang","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/cei.12566","article-title":"T Cell participation in autoreactivity to Nc16a epitopes in bullous pemphigoid","volume":"180","author":"Pickford","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and b cells from bullous pemphigoid (Bp) patients recognize epitopes clustered in distinct regions of Bp180 and Bp230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1600-0625.2006.00522.x","article-title":"Frequency, function and cla expression of Cd4+Cd25+Foxp3+ regulatory T cells in bullous pemphigoid","volume":"16","author":"Rensing-Ehl","year":"2007","journal-title":"Exp Dermatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2011.01378.x","article-title":"Lesional Th17 cells and regulatory T cells in bullous pemphigoid","volume":"20","author":"Arakawa","year":"2011","journal-title":"Exp Dermatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-012-1213-9","article-title":"Circulating Cd4+ Cd25brightfoxp3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients","volume":"304","author":"Quaglino","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12091","article-title":"Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid","volume":"28","author":"Antiga","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13135","article-title":"T Regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid","volume":"42","author":"Gambichler","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8628(20000228)90:5<390::aid-ajmg9>3.0.co;2-m","article-title":"Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome","volume":"90","author":"Ferguson","year":"2000","journal-title":"Am J Med Genet"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.08.047","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (Ipex) associated with pemphigoid nodularis: a case report and review of the literature","volume":"55","author":"McGinness","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jdermsci.2020.08.004","article-title":"Regulatory T cell subsets in bullous pemphigoid and dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid","volume":"100","author":"Muramatsu","year":"2020","journal-title":"J Dermatol Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4110\/in.2022.22.e7","article-title":"Immunopathology and immunotherapy of inflammatory skin diseases","volume":"22","author":"Song","year":"2022","journal-title":"Immune Netw"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1161927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:39:15Z","timestamp":1681709955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1161927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2023.1161927"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1161927","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1161927"}}